SCHEMBL14000174

SCHEMBL14000174

Cc1ccc(N(CC(=O)Nc2ccc(-c3ncon3)cc2)C(=O)C2CCOCC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ SLC6A9 P48067 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ GAA P10253 4/20 0.37
▸ LMNA P02545 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ PIK3CA P42336 2/20 0.37
▸ MTOR P42345 2/20 0.37
▸ PIK3CG P48736 2/20 0.37
▸ CNR1 P21554 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ CCR2 P41597 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17923455 0.90 MAPT (0.37) MAPTALDH1A1MAPK1TDP1GAA
SCHEMBL3557373 0.89 MAPT (0.36) MAPTALDH1A1MAPK1TDP1GAA
SCHEMBL14000170 0.88 ALDH1A1 (0.37) MAPTALDH1A1MAPK1TDP1GAA
SCHEMBL14000172 0.84 GAA (0.37) MAPTALDH1A1SLC6A9MAPK1TDP1
SCHEMBL17923449 0.79 SMN1; SMN2 (0.36) MAPTALDH1A1MAPK1LMNAMEN1
SCHEMBL14000175 0.79 MTOR (0.39) MAPTALDH1A1MAPK1TDP1GAA
SCHEMBL2237688 0.79 HDAC1 (0.39) MAPTLMNAMEN1KMT2AL3MBTL1
SCHEMBL17923453 0.79 MAPT (0.35) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL2242794 0.78 POLB (0.36) MAPTALDH1A1GAAKMT2ANPC1
SCHEMBL3892309 0.77 NPC1 (0.37) MAPTLMNAMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465748-B2 Antiherpesvirus drugs; great pharmacokinetics, good antivirus activity when administered orally at a low dose, high safety profile, less mutagenic concerns; N-(2,6-dimethylphenyl)-N-(2-{[4-(1,3-oxazol-4-yl)phenyl]amino)-2-oxoethyl)tetrahydro-2H-thiopyran-4-carboxamide 1,1-dioxide ASTELLAS PHARMA INC. (JP) 2008-12-16 — — US disclosed
US-7465748-B2 Antiherpesvirus drugs; great pharmacokinetics, good antivirus activity when administered orally at a low dose, high safety profile, less mutagenic concerns; N-(2,6-dimethylphenyl)-N-(2-{[4-(1,3-oxazol-4-yl)phenyl]amino)-2-oxoethyl)tetrahydro-2H-thiopyran-4-carboxamide 1,1-dioxide ASTELLAS PHARMA INC. (JP) 2008-12-16 — — US disclosed
Send feedback